{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T12:29:06Z","timestamp":1763468946577,"version":"3.37.3"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019110","name":"University of Oslo Institute of Basic Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019110","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.imlet.2024.106884","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T15:50:51Z","timestamp":1718898651000},"page":"106884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Reduced EO771-induced tumour growth and increased overall-survival of mice ablated for immune cell-specific catalytic subunit C\u03b22 of protein kinase A"],"prefix":"10.1016","volume":"268","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9039-7683","authenticated-orcid":false,"given":"Shuai","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shrikant","family":"Kolan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaoyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara Louise","family":"Hammarstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Grimolizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda Elin Birkhaug","family":"Stuhr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f8rn Steen","family":"Sk\u00e5lhegg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2024.106884_bib0001","first-page":"D678","article-title":"Specificity in the cAMP\/PKA signaling pathway. Differential expression,regulation, and subcellular localization of subunits of PKA","volume":"5","author":"Skalhegg","year":"2000","journal-title":"Front. Biosci."},{"issue":"4","key":"10.1016\/j.imlet.2024.106884_bib0002","first-page":"285","article-title":"The cAMP-dependent protein kinases and cAMP signal transduction","volume":"5","author":"Beebe","year":"1994","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.imlet.2024.106884_bib0003","series-title":"Annals of the New York Academy of Sciences","first-page":"75","article-title":"The essential role of RI\u03b1 in the maintenance of regulated PKA activity","author":"Amieux","year":"2002"},{"issue":"19","key":"10.1016\/j.imlet.2024.106884_bib0004","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1046\/j.0014-2956.2001.02429.x","article-title":"Identification of novel splice variants of the human catalytic subunit c\u03b2 of cAMP-dependent protein kinase","volume":"268","author":"\u00d8rstavik","year":"2001","journal-title":"Eur. J. Biochem."},{"issue":"3","key":"10.1016\/j.imlet.2024.106884_bib0005","first-page":"630","article-title":"Mutation of the C\u03b1 Subunit of PKA leads to growth retardation and sperm dysfunction","volume":"16","author":"Sk\u00e5lhegg","year":"2002","journal-title":"Mol. Endocrinol."},{"issue":"37","key":"10.1016\/j.imlet.2024.106884_bib0006","doi-asserted-by":"crossref","first-page":"13483","DOI":"10.1073\/pnas.0405580101","article-title":"Sperm-specific protein kinase A catalytic subunit C\u03b12 orchestrates cAMP signaling for male fertility","volume":"101","author":"Nolan","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.imlet.2024.106884_bib0007","doi-asserted-by":"crossref","first-page":"6433","DOI":"10.1073\/pnas.97.12.6433","article-title":"Expression of a nonmyristylated variant of the catalytic subunit of protein kinase A during male germ-cell development","volume":"97","author":"Desseyn","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.imlet.2024.106884_bib0008","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2091-7-20","article-title":"Identification, cloning and characterization of a novel 47 kDa murine PKA C subunit homologous to human and bovine Cbeta2","volume":"7","author":"Funderud","year":"2006","journal-title":"BMC Biochem."},{"issue":"11","key":"10.1016\/j.imlet.2024.106884_bib0009","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/eji.201646809","article-title":"Ablation of the C\u03b22 subunit of PKA in immune cells leads to increased susceptibility to systemic inflammation in mice","volume":"47","author":"Moen","year":"2017","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2024.106884_bib0010","doi-asserted-by":"crossref","first-page":"111.e1","DOI":"10.1016\/j.urolonc.2016.10.002","article-title":"Observed correlation between the expression levels of catalytic subunit, C\u03b22, of cyclic adenosine monophosphate\u2013dependent protein kinase and prostate cancer aggressiveness","volume":"35","author":"Moen","year":"2017","journal-title":"Urologic Oncol.: Seminars and Original Investig."},{"issue":"2","key":"10.1016\/j.imlet.2024.106884_bib0011","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cellsig.2008.10.013","article-title":"Isoform-specific regulation of immune cell reactivity by the catalytic subunit of protein kinase A (PKA","volume":"21","author":"Funderud","year":"2009","journal-title":"Cell Signal."},{"issue":"7","key":"10.1016\/j.imlet.2024.106884_bib0012","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/j.1742-4658.2005.04568.x","article-title":"Identification and characterization of novel PKA holoenzymes in human T lymphocytes","volume":"272","author":"\u00d8rstavik","year":"2005","journal-title":"FEBS J."},{"issue":"22","key":"10.1016\/j.imlet.2024.106884_bib0013","doi-asserted-by":"crossref","first-page":"15707","DOI":"10.1016\/S0021-9258(19)49593-8","article-title":"Cyclic AMP-dependent protein kinase type I mediates the inhibitory effects of 3\u2019,5\u2019-cyclic adenosine monophosphate on cell replication in human T lymphocytes","volume":"267","author":"Skalhegg","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.imlet.2024.106884_bib0014","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/eji.1830260617","article-title":"Cyclic AMP-dependent protein kinase (cAK) in human B cells: co-localization of type I cAK (RI alpha 2 C2) with the antigen receptor during anti-immunoglobulin-induced B cell activation","volume":"26","author":"Levy","year":"1996","journal-title":"Eur. J. Immunol."},{"issue":"9","key":"10.1016\/j.imlet.2024.106884_bib0015","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1074\/jbc.272.9.5495","article-title":"Selective activation of cAMP-dependent protein kinase type I inhibits rat natural killer cell cytotoxicity","volume":"272","author":"Torgersen","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"5143","key":"10.1016\/j.imlet.2024.106884_bib0016","first-page":"84","article-title":"Location of cAMP-Dependent Protein Kinase Type I with the TCR-CD3 Complex","volume":"263","author":"Sk\u00e5lhegg","year":"1994","journal-title":"Science (1979)"},{"issue":"4","key":"10.1016\/j.imlet.2024.106884_bib0017","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1084\/jem.193.4.497","article-title":"Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor","volume":"193","author":"Vang","year":"2001","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.imlet.2024.106884_bib0018","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1172\/JCI0214794","article-title":"Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases","volume":"109","author":"Hermiston","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2024.106884_bib0019","article-title":"The molecular basis for specificity at the level of the protein kinase a catalytic subunit","volume":"9","author":"S\u00f8berg","year":"2018"},{"issue":"6","key":"10.1016\/j.imlet.2024.106884_bib0020","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2174\/1389450054863644","article-title":"Protein kinase A (PKA)\u2013a potential target for therapeutic intervention of dysfunctional immune cells","volume":"6","author":"Sk\u00e5lhegg","year":"2005","journal-title":"Curr. Drug Targets"},{"issue":"1","key":"10.1016\/j.imlet.2024.106884_bib0021","first-page":"45","article-title":"The clinical role of the TME in solid cancer","volume":"120","author":"Giraldo","year":"2018","journal-title":"British Journal of Cancer 2018 120:1"},{"issue":"24","key":"10.1016\/j.imlet.2024.106884_bib0022","first-page":"6034","article-title":"Tumor-infiltrating lymphocytes and immune response in HER2-Positive breast cancer","volume":"14","author":"Luque","year":"2022","journal-title":"Cancers 2022, Vol. 14, Page 6034"},{"issue":"6","key":"10.1016\/j.imlet.2024.106884_bib0023","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.imlet.2024.106884_bib0024","first-page":"237","article-title":"Functional and molecular characterisation of EO771.LMB tumours, a new C57BL\/6-mouse-derived model of spontaneously metastatic mammary cancer","volume":"8","author":"Johnstone","year":"2015","journal-title":"Dis Model Mech"},{"issue":"21","key":"10.1016\/j.imlet.2024.106884_bib0025","doi-asserted-by":"crossref","first-page":"8074","DOI":"10.1002\/cam4.3295","article-title":"EO771, is it a well-characterized cell line for mouse mammary cancer model? Limit and uncertainty","volume":"9","author":"Naour","year":"2020","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.imlet.2024.106884_bib0026","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-020-01418-1","article-title":"EO771, the first luminal B mammary cancer cell line from C57BL\/6 mice","volume":"20","author":"Naour","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"8","key":"10.1016\/j.imlet.2024.106884_bib0027","first-page":"1","article-title":"Oxygen-dependent regulation of tumor growth and metastasis in human breast cancer xenografts","volume":"12","author":"Sletta","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.imlet.2024.106884_bib0028","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00300234","article-title":"Determination of subcutaneous tumor size in athymic (nude) mice","volume":"24","author":"Tomayko","year":"1989","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"5","key":"10.1016\/j.imlet.2024.106884_bib0029","article-title":"Cutting sections of paraffin-embedded tissues","volume":"3","author":"Fischer","year":"2008","journal-title":"Cold Spring Harb. Protoc."},{"issue":"5","key":"10.1016\/j.imlet.2024.106884_bib0030","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot4986","article-title":"Hematoxylin and eosin staining of tissueand cell sections","volume":"3","author":"Fischer","year":"2008","journal-title":"Cold Spring Harb. Protoc."},{"issue":"7","key":"10.1016\/j.imlet.2024.106884_bib0031","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"issue":"3","key":"10.1016\/j.imlet.2024.106884_bib0032","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/JP9.0000000000000024","article-title":"A note on error bars as a graphical representation of the variability of data in biomedical research: choosing between standard deviation and standard error of the mean","volume":"2","author":"Tang","year":"2019","journal-title":"J Pancreatol"},{"issue":"5","key":"10.1016\/j.imlet.2024.106884_bib0033","first-page":"817","article-title":"Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas","volume":"3","author":"M\u00e9nard","year":"1997","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.imlet.2024.106884_bib0034","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/bjc.2012.347","article-title":"The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer","volume":"107","author":"Mohammed","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.imlet.2024.106884_bib0035","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1200\/JCO.2011.41.0902","article-title":"Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98","volume":"31","author":"Loi","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"15","key":"10.1016\/j.imlet.2024.106884_bib0036","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1200\/JCO.2010.30.5037","article-title":"Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer","volume":"29","author":"Mahmoud","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.imlet.2024.106884_bib0037","first-page":"298","article-title":"The immune contexture in human tumours: impact on clinical outcome","volume":"12","author":"Fridman","year":"2012"},{"key":"10.1016\/j.imlet.2024.106884_bib0038","first-page":"399","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017"},{"key":"10.1016\/j.imlet.2024.106884_bib0039","unstructured":"A. Ewens, E. Mihich, M. J. Ehrke, Distant metastasis from subcutaneously grown E0771 medullary breast adenocarcinoma, Anticancer Res 25 (2005) 6B 3905\u20133915."},{"issue":"13","key":"10.1016\/j.imlet.2024.106884_bib0040","doi-asserted-by":"crossref","first-page":"500","DOI":"10.5694\/j.1326-5377.1960.tb73127.x","article-title":"The Principles of Humane Experimental Technique","volume":"1","year":"1960","journal-title":"Med. J. Aust."},{"issue":"18","key":"10.1016\/j.imlet.2024.106884_bib0041","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The tumor microenvironment innately modulates cancer progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.imlet.2024.106884_bib0042","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/cncr.23712","article-title":"Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer","volume":"113","author":"Kawai","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.imlet.2024.106884_bib0043","article-title":"Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2024.106884_bib0044","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40257-018-0389-y","article-title":"Mechanisms of resistance to immune checkpoint blockade","volume":"20","author":"Liu","year":"2019","journal-title":"Am. J. Clin. Dermatol."},{"issue":"6","key":"10.1016\/j.imlet.2024.106884_bib0045","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.immuni.2016.06.001","article-title":"Resistance mechanisms to immune-checkpoint blockade in cancer: tumor-intrinsic and -extrinsic factors","volume":"44","author":"Pitt","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2024.106884_bib0046","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.3389\/fimmu.2020.570041","article-title":"Targeting hypoxia-A2A adenosinergic immunosuppression of antitumor T Cells during cancer immunotherapy","volume":"11","author":"Steingold","year":"2020","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2024.106884_bib0047","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3390\/cells10051006","article-title":"Tumour hypoxia-mediated immunosuppression: mechanisms and therapeutic approaches to improve cancer immunotherapy","volume":"10","author":"Fu","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.imlet.2024.106884_bib0048","first-page":"453","article-title":"The Biology of Interleukin-2","volume":"26","author":"Malek","year":"2008","journal-title":"https:\/\/doi.org\/10.1146\/annurev.immunol.26.021607.090357"},{"issue":"10","key":"10.1016\/j.imlet.2024.106884_bib0049","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1016\/j.celrep.2016.11.035","article-title":"The Csk-Associated Adaptor PAG Inhibits Effector T Cell Activation in Cooperation with Phosphatase PTPN22 and Dok Adaptors","volume":"17","author":"Davidson","year":"2016","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/j.imlet.2024.106884_bib0050","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.4049\/jimmunol.179.8.5159","article-title":"Inhibition of T cell activation by cyclic adenosine 5\u2019-monophosphate requires lipid raft targeting of protein kinase A type I by the A-kinase anchoring protein ezrin","volume":"179","author":"Ruppelt","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2024.106884_bib0051","first-page":"74","article-title":"The Multifaceted Role of Th1, Th9, and Th17 Cells in Immune Checkpoint Inhibition Therapy","volume":"12","author":"Lee","year":"2021","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.imlet.2024.106884_bib0052","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1080\/21645515.2019.1710413","article-title":"Targeting the IL-9 pathway in cancer immunotherapy","volume":"16","author":"Zheng","year":"2020","journal-title":"Hum. Vaccin. Immunother."},{"issue":"6","key":"10.1016\/j.imlet.2024.106884_bib0053","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.ccell.2018.05.004","article-title":"Th9 cells represent a unique subset of CD4+ T Cells endowed with the ability to eradicate advanced tumors","volume":"33","author":"Lu","year":"2018","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.imlet.2024.106884_bib0054","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1158\/0008-5472.CAN-06-4249","article-title":"Inhibition of cytokine production and cytotoxic activity of human antimelanoma specific CD8+ and CD4+ T Lymphocytes by Adenosine-Protein Kinase A Type I Signaling","volume":"67","author":"Raskovalova","year":"2007","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.imlet.2024.106884_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107643","article-title":"Protein Kinase A catalytic subunit is a molecular switch that promotes the pro-tumoral function of macrophages","volume":"31","author":"Na","year":"2020","journal-title":"Cell Rep."},{"issue":"16","key":"10.1016\/j.imlet.2024.106884_bib0056","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1158\/0008-5472.CAN-04-0465","article-title":"Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-Cell receptor expression and antigen-specific T-Cell responses","volume":"64","author":"Rodriguez","year":"2004","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.imlet.2024.106884_bib0057","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ccell.2014.09.006","article-title":"Macrophage IL-10 Blocks CD8+ T Cell-Dependent responses to chemotherapy by Suppressing IL-12 expression in intratumoral dendritic cells","volume":"26","author":"Ruffell","year":"2014","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.imlet.2024.106884_bib0058","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","article-title":"CD8+ T cell differentiation and dysfunction in cancer","volume":"22","author":"Philip","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2024.106884_bib0059","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/B978-0-12-803077-6.00009-6","article-title":"Cell culture: growing cells as model systems in vitro","author":"Segeritz","year":"2017","journal-title":"Basic Sci. Method. Clinical Res."},{"issue":"7","key":"10.1016\/j.imlet.2024.106884_bib0060","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jnci\/djt007","article-title":"The clinical relevance of cancer cell lines","volume":"105","author":"Gillet","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.imlet.2024.106884_bib0061","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10549-005-9067-x","article-title":"From genetic abnormality to metastases: murine models of breast cancer and their use in the development of anticancer therapies","volume":"96","author":"Ottewell","year":"2006","journal-title":"Breast Cancer Res. Treat."},{"issue":"3","key":"10.1016\/j.imlet.2024.106884_bib0062","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2353\/ajpath.2007.060929","article-title":"Murine models to evaluate novel and conventional therapeutic strategies for cancer","volume":"170","author":"Talmadge","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.imlet.2024.106884_bib0063","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.surg.2013.02.002","article-title":"Resection of the primary tumor improves survival in metastatic breast cancer by reduction of overall tumor burden","volume":"153","author":"Rashid","year":"2013","journal-title":"Surgery"},{"issue":"7","key":"10.1016\/j.imlet.2024.106884_bib0064","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.cell.2009.11.025","article-title":"Tumor self-seeding by circulating cancer cells","volume":"139","author":"Kim","year":"2009","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.imlet.2024.106884_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-019-0789-4","article-title":"Moving forward to address key unanswered questions on targeting PD-1\/PD-L1 in cancer: limitations in preclinical models and the need to incorporate human modifying factors","volume":"7","author":"Le","year":"2019","journal-title":"J. Immunother. Cancer"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247824000580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247824000580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,6]],"date-time":"2024-10-06T18:38:04Z","timestamp":1728239884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247824000580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":65,"alternative-id":["S0165247824000580"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2024.106884","relation":{},"ISSN":["0165-2478"],"issn-type":[{"type":"print","value":"0165-2478"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced EO771-induced tumour growth and increased overall-survival of mice ablated for immune cell-specific catalytic subunit C\u03b22 of protein kinase A","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2024.106884","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.","name":"copyright","label":"Copyright"}],"article-number":"106884"}}